Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells-Reference-Cited by-同舟云学术

Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells

Published:2015-09-10 Issue:31 Volume:6 Page:31997-32012
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Shafi Ayesha A.¹,Putluri Vasanta¹²³,Arnold James M.²,Tsouko Efrosini⁴,Maity Suman¹²³,Roberts Justin M.¹,Coarfa Cristian¹³,Frigo Daniel E.⁴⁵,Putluri Nagireddy¹²³,Sreekumar Arun¹²³,Weigel Nancy L.¹⁶

Affiliation:

1. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA

2. Verna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, Houston, TX, USA

3. Alkek Center for Molecular Discovery, Baylor College of Medicine, Houston, TX, USA

4. Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX, USA

5. Genomic Medicine Program, Houston Methodist Research Institute, Houston, TX, USA

6. Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progression;Cancer Letters;2024-04

2. Metabolic and imaging phenotypes associated withRB1loss in castrate resistant prostate cancer;2023-11-17

3. The functional roles of m6A modification in prostate cancer;PROTEOMICS – Clinical Applications;2023-10-13

4. YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH;Molecular and Cellular Biochemistry;2023-09-29

5. A Splicing Transcriptome-Wide Association Study Identifies Candidate Altered Splicing for Prostate Cancer Risk;OMICS: A Journal of Integrative Biology;2023-08-01